[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/pages/docs/Benef/index.md) >> Individual ID:PBN__Benef_65 

# __Vaccine design and analysis__

## Articles mentionning this Benefit

* [CIDO, a community-based ontology for coronavirus disease knowledge and data integration, sharing, and analysis](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_13.md)

## Category to which it belongs

* [Expanded vaccination capabilities lead to improved healthcare capacity, equitable distribution, and enhanced response and technological capabilities.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_31.md)

## Description of actual returns pertaining to this benefit

* [Private investors can benefit indirectly from the improved vaccine design and analysis, potentially leading to the development of effective vaccines, attracting investment and commercial interest.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_65.md)

## Name of the Benefit

CIDO facilitates the annotation and modeling of vaccine candidates, aiding in the design and analysis of potential vaccines against coronaviruses.

## Risks which can benefit from this action

* [Annotating and modeling vaccine candidates](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_58.md)

## Stakeholders benefitting from this Benefit

* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_46.md)
* [Scientists](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)

